Find News

Filter articles

Applied Filters

Showing 1 to 10 of 1623 results

ResMed and Fisher & Paykel settle patent disputes

New Zealand, US22-02-2019

American medical device maker ResMed and New Zealand-based competitor Fisher & Paykel have agreed to settle a global patent dispute over medical devices.

Indivior to launch generic after SCOTUS refuses petition


Indivior has launched a generic version of its opioid addiction drug Suboxone (buprenorphine and naloxone) Film, one day after the US Supreme Court denied its request to put a lower court’s ruling on hold.

Mexican Senate launches bill to modify patented drug prices


The majority parliament group of the Mexican Senate has introduced a bill to modify the current scheme for setting maximum sale prices of patented medicines and supplies.

Federal Circuit disqualifies Katten from Mylan appeals


The US Court of Appeals for the Federal Circuit yesterday disqualified law firm Katten Muchin Rosenman from representing Mylan in three appeals before the court.

FDA publishes guidance on Competitive Generic Therapies


The US Food and Drug Administration has published new draft guidance on a pathway intended to boost the development of generics and lower drug prices.

J&J to buy surgical robotics company for $3.4bn

US18-02-2019Mergers & acquisitions

Johnson & Johnson has announced plans to strengthen its robotics programme with the addition of Silicon Valley-based Auris Health to its business.

Boehringer Ingelheim teams up with IBM to explore blockchain


The Canadian units of IBM and pharmaceutical company Boehringer Ingelheim have united to explore the use of blockchain technology in clinical trials.

Roche agrees to pay $21m to settle Enzo infringement suit


Swiss pharmaceutical company Roche Diagnostics has agreed to pay $21 million as part of a settlement to a patent infringement case with New York-based Enzo Biochem.

Clarivate announces new Life Science Alliances programme


Global information company Clarivate Analytics has launched a “Life Science Alliances Program” to provide drug and medical device developers a new way to advance their research and development.

University of California to be granted CRISPR patent


The University of California will soon be granted a patent related to the gene-editing technology CRISPR, according to a notice of allowance by the US Patent and Trademark Office.

Showing 1 to 10 of 1623 results